MarzlM, Merz CN, Boden WE, Bonow RO, Capozza PG, Chn WM, DeMar AN, GuarG, HuqA, Morrone D, Patel MR, Wetraub WS. Obstructe coronary atheroscleros and chem heart dease: an eluse lk! J Am Coll Cardl. 2012 Sep 11;60(11):951-6. do 10.1016/j.jacc.2012.02.082. Cannon RO 3rd. Mrovascular anga and the contug demma of chest pa wh normal coronary anggrams. J Am Coll Cardl. 2009 Sep 1;54(10):877-85. do 10.1016/j.jacc.2009.03.080. Deedwan PC, Carbajal EV. Sent chem durg day le an dependent predtor of mortaly stable anga. Cculatn. 1990 Mar;81(3):748-56. do 10.1161/01.c.81.3.748. Gbons RJ, Abrams J, Chatterjee K, Daley J, Deedwan PC, Douglas JS, Ferguson TB Jr, Fn SD, Fraker TD Jr, Gard JM, O'Rourke RA, Pasternak RC, Wlms SV; Ameran College of Cardlogy; Ameran Heart Assoctn Task Force on practe gueles (Commtee on the Management of Patnts Wh Chron Stable Anga). ACC/AHA 2002 guele update for the management of patnts wh chron stable anga--summary artle: a report of the Ameran College of Cardlogy/Ameran Heart Assoctn Task Force on practe gueles (Commtee on the Management of Patnts Wh Chron Stable Anga). J Am Coll Cardl. 2003 Jan 1;41(1):159-68. do 10.1016/s0735-1097(02)02848-6. No abstract avaable. Saunders JT, NambV, de Lemos JA, Chambless LE, VanSS, Boerwkle E, Hoogeveen RC, L X, Astor BC, Mosley TH, Folsom AR, Hes G, Coresh J, Ballantyne CM. Cardc tropon T measured by a hhly sense assay predts coronary heart dease, heart faure, and mortaly the Atheroscleros Rk Communs Study. Cculatn. 2011 Apr 5;123(13):1367-76. do 10.1161/CCULATNAHA.110.005264. Epub 2011 Mar 21. Hallen J, Johansen OE, Bkeland K Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D. Determants and prognost platns of cardc tropon T measured by a sense assay type 2 dbetes mellus. Cardvasc Dbetol. 2010 Sep 15;9:52. do 10.1186/1475-2840-9-52. Fornengo P, Bos A, EpanG, Pallco O, Mancuso A, Pascale C. Prevalence of sent myocardl chaem new-onset mdle-aged Type 2 dbet patnts whout other cardvascular rk factors. Dbet Med. 2006 Jul;23(7):775-9. do 10.1111/j.1464-5491.2006.01910.x. Sprague RS, Ellsworth ML. Vascular dease pre-dbetes: new shts dered from systems blogy. Mo Med. 2010 Jul-Aug;107(4):265-9. Sgleton JR, Smh AG, Russell JW, Feldman EL. Mrovascular complatns of paed glucose tolerance. Dbetes. 2003 Dec;52(12):2867-73. do 10.2337/dbetes.52.12.2867. Zgler D, Rathmann W, Dkhaus T, Meger C, Mlck A; KORA Study Group. Prevalence of polyneuropathy pre-dbetes and dbetes assocted wh abdomal obesy and macroangpathy: the MONA/KORA Augsburg Surveys S2 and S3. Dbetes Care. 2008 Mar;31(3):464-9. do 10.2337/dc07-1796. Epub 2007 Nov 26. Aranda JM Jr, Hl J. Cardc transplant vasculopathy. Chest. 2000 Dec;118(6):1792-800. do 10.1378/chest.118.6.1792. Omland T, de Lemos JA, Sabate MS, ChrtophCA, Re MM, JablonskKA, Tjora S, DomanskMJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Preventn of Events wh Angtens Convertg Enzyme hn (PEACE) Trl vestators. A sense cardc tropon T assay stable coronary artery dease. N Engl J Med. 2009 Dec 24;361(26):2538-47. do 10.1056/NEJMoa0805299. Epub 2009 Nov 25. LatR, Masson S, Anand , Msov E, Carlson M, Vago T, AngelL, Barlera S, Parrello G, MaggnAP, TognonG, Cohn JN; Val-HeFT vestators. Prognost value of very low plasma concentratns of tropon T patnts wh stable chron heart faure. Cculatn. 2007 Sep 11;116(11):1242-9. do 10.1161/CCULATNAHA.106.655076. Epub 2007 Aug 13. Rub J, Matsusha K, Ballantyne CM, Hoogeveen R, Coresh J, Selv E. Chron hyperglycem and subclal myocardl jury. J Am Coll Cardl. 2012 Jan 31;59(5):484-9. do 10.1016/j.jacc.2011.10.875. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, RohatgA, Hash Berry JD, Das SR, Morrow DA, McGue DK. Assoctn of tropon T detected wh a hhly sense assay and cardc structure and mortaly rk the general populatn. JAMA. 2010 Dec 8;304(22):2503-12. do 10.1001/jama.2010.1768. Erratum : JAMA. 2011 Mar 23;305(12):1200. deFpCR, de Lemos JA, Chrtenson RH, Gottdner JS, Kop WJ, Zhan M, Seler SL. Assoctn of serl measures of cardc tropon T usg a sense assay wh cent heart faure and cardvascular mortaly older adults. JAMA. 2010 Dec 8;304(22):2494-502. do 10.1001/jama.2010.1708. Epub 2010 Nov 15. Nad MA, Rekhraj S, WeL, L TK, Davson J, MacDonald TM, Lang CC, Dow E, Struthers AD. provg the prary preventn of cardvascular events by usg bmarkers to enty duals wh sent heart dease. J Am Coll Cardl. 2012 Sep 11;60(11):960-8. do 10.1016/j.jacc.2012.04.049. Epub 2012 Aug 22. Stone PH, Chaman BR, Stocke K, Sano J, DeVault A, Koch GG. The antchem mechanm of actn of ranolaze stable chem heart dease. J Am Coll Cardl. 2010 Sep 14;56(12):934-42. do 10.1016/j.jacc.2010.04.042. Deshmukh SH, Patel SR, PassE, Mdrescu C, Hermance EV, fanto MN, Coppola JT, Stanoae CS. Ranolaze proves endothell functn patnts wh stable coronary artery dease. Coron Artery D. 2009 Aug;20(5):343-7. do 10.1097/MCA.0b013e32832a198b. Kosorod M, Arnold SV, Spertus JA, McGue DK, LY, Yue P, Ben-Yehuda O, Katz A, Jones PG, Olmsted A, BelardellL, Chaman BR. Evaluatn of ranolaze patnts wh type 2 dbetes mellus and chron stable anga: results from the TERA randomed clal trl (Type 2 Dbetes Evaluatn of Ranolaze Subjects Wh Chron Stable Anga). J Am Coll Cardl. 2013 May 21;61(20):2038-45. do 10.1016/j.jacc.2013.02.011. Epub 2013 Mar 10. Gead Scnces, c. Ranolaze vestator's Brochure. Sectn 3.2.2 Placebo Tablets, 30 Mar 2012. FDA drug label for Ranolaze (Ranexa). Accessed v FDA webse on 05 October 2012. Last revn Dec 2011. Reference : 3164047. Does Ranolazine Decrease Biomarkers That Indicate Evidence of Myocardial Damage in Diabetics With Stable Ischemic Heart Disease? A Double-blinded, Randomized, Placebo Controlled Trial